SCHEMBL12376574

SCHEMBL12376574

CNC(=O)c1coc(C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 2/20 0.39
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC2 Q92769 1/20 0.38
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
MAPK14 Q16539 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
HTT P42858 2/20 0.36
HPGD P15428 1/20 0.36
PLK1 P53350 3/20 0.35
TP53 P04637 2/20 0.34
PLAU P00749 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
MTNR1A P48039 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12411770 0.83 PLK1 (0.39) HDAC8HDAC6HDAC2EPHX2NR1H4
SCHEMBL19454729 0.79 MEN1 (0.44) RAF1TDP1SMN1; SMN2TP53NPC1
SCHEMBL19449362 0.79 CHRM2 (0.38) RAF1EPHX2NR1H4TSHRHPGD
SCHEMBL13631428 0.75 NPC1 (0.53) HDAC8HDAC6HDAC2TDP1SMN1; SMN2
SCHEMBL27960131 0.73 HDAC8 (0.41) HDAC8HDAC6HDAC2TDP1SMN1; SMN2
SCHEMBL12794022 0.72 HTT (0.40) HDAC8HDAC6HDAC2TDP1SMN1; SMN2
SCHEMBL13368525 0.70 PLK1 (0.47) HDAC8HDAC6HDAC2TDP1SMN1; SMN2
SCHEMBL8476628 0.69 CA2 (0.40) HDAC8HDAC6HDAC2TDP1SMN1; SMN2
SCHEMBL4488736 0.69 L3MBTL1 (0.44) HDAC8HDAC6HDAC2TDP1SMN1; SMN2
SCHEMBL10183617 0.68 HDAC6 (0.53) HDAC8HDAC6HDAC2EPHX2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003662-B2 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. (US) 2011-08-23 US disclosed
US-20100256356-A1 HETEROBICYCLIC PYRAZOLE COMPOUNDS AND METHODS OF USE ARRAY BIOPHARMA INC. (US) 2010-10-07 US disclosed
US-7723330-B2 Heterobicyclic pyrazole compounds and methods of use ARRAY BIOPHARMA INC. (US) 2010-05-25 US disclosed
US-7723330-B2 Heterobicyclic pyrazole compounds and methods of use ARRAY BIOPHARMA INC. (US) 2010-05-25 US disclosed
US-20070238726-A1 Heterobicyclic pyrazole compounds and methods of use GENENTECH, INC. 2007-10-11 US disclosed
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ERBB2, LCK, SRC RAF1 236/4885HDAC8 3449/4885HDAC6 2467/4885
US-20100256356-A1 HETEROBICYCLIC PYRAZOLE COMPOUNDS AND METHODS OF USE ROR1, CYP11B1, CYP11B2 RAF1 288/4885HDAC8 3010/4885HDAC6 2092/4885
US-20070238726-A1 Heterobicyclic pyrazole compounds and methods of use ROR1, CYP11B1, CYP11B2 RAF1 288/4885HDAC8 3010/4885HDAC6 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.